Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses

Mass vaccination campaigns are essential to control the ongoing novel severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) pandemic. The Covishield vaccine consists of the replication-deficient simian adenovirus vector ChAdOx1, which contains the full-length structural spike protein of SARS-...

Descripción completa

Detalles Bibliográficos
Autores principales: Eyer-Silva, Walter de Araujo, Leme, Lidiane Simões de Carvalho Paes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Medicina Tropical - SBMT 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131775/
https://www.ncbi.nlm.nih.gov/pubmed/35613221
http://dx.doi.org/10.1590/0037-8682-0063-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131775/
https://www.ncbi.nlm.nih.gov/pubmed/35613221
http://dx.doi.org/10.1590/0037-8682-0063-2022

Ejemplares similares